<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>03573026625023</udiDi>
    <basicUdiDi>357302BUDI000820TQ</basicUdiDi>
    <tradeName>ETEST® Norfloxacin (NX)</tradeName>
    <deviceName>ETEST® Norfloxacin (NX)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543049</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:14.736Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026625009</udiDi>
    <basicUdiDi>357302BUDI000818U5</basicUdiDi>
    <tradeName>ETEST® Nalidixic-acid (NA)</tradeName>
    <deviceName>ETEST® Nalidixic-acid (NA)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543047</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:12.325Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624989</udiDi>
    <basicUdiDi>357302BUDI002028TE</basicUdiDi>
    <tradeName>ETEST® MBL Meropenem/Meropenem + EDTA (MP/MPI)</tradeName>
    <deviceName>ETEST® MBL Meropenem/Meropenem + EDTA (MP/MPI)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080590</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543045</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:09.922Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624965</udiDi>
    <basicUdiDi>357302BUDI000824TY</basicUdiDi>
    <tradeName>ETEST® Nitrofurantoin (NI)</tradeName>
    <deviceName>ETEST® Nitrofurantoin (NI)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543043</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:09.126Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624941</udiDi>
    <basicUdiDi>357302BUDI000912TW</basicUdiDi>
    <tradeName>ETEST® Streptomycin (SM)</tradeName>
    <deviceName>ETEST® Streptomycin (SM)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543041</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:07.522Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624903</udiDi>
    <basicUdiDi>357302BUDI000816TZ</basicUdiDi>
    <tradeName>ETEST® Mupirocin (MU)</tradeName>
    <deviceName>ETEST® Mupirocin (MU)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543037</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:05.165Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624859</udiDi>
    <basicUdiDi>357302BUDI002027TC</basicUdiDi>
    <tradeName>ETEST® MBL Imipenem/Imipenem + EDTA (IP/IPI)</tradeName>
    <deviceName>ETEST® MBL Imipenem/Imipenem + EDTA (IP/IPI)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080590</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - OTHER</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543032</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:03.519Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624798</udiDi>
    <basicUdiDi>357302BUDI000839UD</basicUdiDi>
    <tradeName>ETEST® Ceftaroline (CPT)</tradeName>
    <deviceName>ETEST® Ceftaroline (CPT)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543026</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:02.732Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624750</udiDi>
    <basicUdiDi>357302BUDI000834U3</basicUdiDi>
    <tradeName>ETEST® ESBL Cefepime/cefepime + clavulanic acid (PM/PML)</tradeName>
    <deviceName>ETEST® ESBL Cefepime/cefepime + clavulanic acid (PM/PML)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>543022</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T18:00:01.127Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624736</udiDi>
    <basicUdiDi>357302BUDI000826U4</basicUdiDi>
    <tradeName>ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)</tradeName>
    <deviceName>ETEST® ESBL Cefotaxime/cefotaxime + clavulanic acid (CT/CTL)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>AB pazarı için değil</deviceStatus>
    <reference>543020</reference>
    <placedOnMarketCountry></placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:58.710Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624712</udiDi>
    <basicUdiDi>357302BUDI000828U8</basicUdiDi>
    <tradeName>ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)</tradeName>
    <deviceName>ETEST® ESBL Ceftazidime/ceftazidime + clavulanic acid (TZ/TZL)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080505</emdnCode>
    <emdnDescription>TARGETED RESISTANCE TESTS - ESBL</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542962</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:57.125Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026624019</udiDi>
    <basicUdiDi>357302BUDI002013SZ</basicUdiDi>
    <tradeName>ETEST® Imipenem/Relebactam (IPR)</tradeName>
    <deviceName>ETEST® Imipenem/Relebactam (IPR)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542988</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:54.726Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623944</udiDi>
    <basicUdiDi>357302BUDI000771U4</basicUdiDi>
    <tradeName>ETEST® Cefixime (IX)</tradeName>
    <deviceName>ETEST® Cefixime (IX)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542981</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:52.314Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623999</udiDi>
    <basicUdiDi>357302BUDI002036TD</basicUdiDi>
    <tradeName>ETEST® Meropenem/Vaborbactam (MEV)</tradeName>
    <deviceName>ETEST® Meropenem/Vaborbactam (MEV)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542986</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:49.903Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623968</udiDi>
    <basicUdiDi>357302BUDI000792UC</basicUdiDi>
    <tradeName>ETEST® Moxifloxacin (MX)</tradeName>
    <deviceName>ETEST® Moxifloxacin (MX)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542983</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:49.184Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623845</udiDi>
    <basicUdiDi>357302BUDI000766UB</basicUdiDi>
    <tradeName>ETEST® Aztreonam (AT)</tradeName>
    <deviceName>ETEST® Aztreonam (AT)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542971</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:33.026Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623807</udiDi>
    <basicUdiDi>357302BUDI000802TN</basicUdiDi>
    <tradeName>ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)</tradeName>
    <deviceName>ETEST® Trimethoprim/sulfamethoxazole (1/19) (TS)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542967</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:31.422Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026623784</udiDi>
    <basicUdiDi>357302BUDI000788UM</basicUdiDi>
    <tradeName>ETEST® Levofloxacin (LE)</tradeName>
    <deviceName>ETEST® Levofloxacin (LE)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542965</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:30.626Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622954</udiDi>
    <basicUdiDi>357302BUDI000903TV</basicUdiDi>
    <tradeName>VITEK® 2 AST-N416</tradeName>
    <deviceName>VITEK® 2 AST-N416</deviceName>
    <manufacturerName>bioMérieux, Inc.</manufacturerName>
    <manufacturerSrn>US-MF-000011802</manufacturerSrn>
    <authorisedRepresentativeName>bioMérieux SA</authorisedRepresentativeName>
    <authorisedRepresentativeSrn>FR-AR-000004435</authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080107</emdnCode>
    <emdnDescription>GRAM NEGATIVE SUSCEPTIBILITY TESTING - AUTOMATED</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542943</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:25.830Z</lastUpdated>
  </row>
  <row>
    <udiDi>03573026622374</udiDi>
    <basicUdiDi>357302BUDI000804TS</basicUdiDi>
    <tradeName>ETEST® Vancomycin (VA)</tradeName>
    <deviceName>ETEST® Vancomycin (VA)</deviceName>
    <manufacturerName>bioMérieux SA</manufacturerName>
    <manufacturerSrn>FR-MF-000004436</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>IVD Sınıf B</riskClass>
    <legislation>IVDR 2017/746</legislation>
    <emdnCode>W0104080501</emdnCode>
    <emdnDescription>MIC SYSTEMS - DILUTION METHODS (INCL. E-TEST)</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>542900</reference>
    <placedOnMarketCountry>France</placedOnMarketCountry>
    <lastUpdated>2026-07-30T17:59:25.024Z</lastUpdated>
  </row>
</eudamedExport>